Lucide Ledger

A filing-first public record from Lucide House.

Issue 001 | U.S. Pilot | US

HAO

Haoxi Health Technology Ltd

Screen state: Needs Review Source state: Stale Filing 20-F | 2025-10-20 Filing currency: USD
Open Filing Back to Register Report a correction
Internal NCAV Discount 94.4%

GNNI internal NCAV discount calculation. Market context inputs are retained internally and are not displayed.

Current Assets
19,604,560USD
Total Liabilities
4,218,884USD
NCAV
15,385,676USD
Cash
n/a
NCAV per share
9.09USD/share
Evidence
2 annual | 3 quarterly

Mary filing review

Financial Statement Evidence

Deterministic observations from the frozen Mary Reason Card. They annotate filing evidence and do not determine screen inclusion.

Not captured in this issue’s Mary run.

This archived issue is not backfilled with observations from a later screening run.

Business Profile

Published only when a substantive filing-text profile has been prepared for this issue.

Not available for this issue.

A substantive filing-text profile was not prepared for this company. Financial statement evidence and filing links remain available above for direct inspection.

Share Count & Per-Share Comparability

Data Vault has not published the normalized share-count artifact for this company.

Known Unknowns

Only 3 quarterly periods available from Data Vault for this company.

Medium | Share Count

The current U.S. Pilot does not yet evaluate share-count trends or post-filing dilution beyond Mary's screening flags.

Low | Classification

U.S. Pilot rows are surfaced for source inspection and may still need manual business classification review.

Medium | Filing

Some rows are based on older filing data and require manual freshness review.

Annual Financials

Latest annual periods, newest first. Missing cells render as n/a.

Metric
2025-06-30
20-F
USD
2024-06-30
20-F
USD
Revenue 537,646 48,519,836
Operating Income -1,999,903 1,717,248
Net Income 3,876,680 1,291,667
Cash From Operations -3,358,082 -747,576
Capex n/a -55,367
Free Cash Flow n/a -802,943
Cash And Equivalents n/a 6,655,734
Accounts Receivable 460,272 226,747
Inventory n/a n/a
Total Current Assets 19,604,560 15,379,830
Total Assets 21,595,314 15,506,573
Total Current Liabilities 3,885,065 3,866,575
Total Liabilities 4,218,884 4,234,618
Shareholders Equity 17,376,430 11,271,955
Shares Outstanding n/a n/a
Shares Outstanding Diluted n/a n/a
Weighted Avg Shares Diluted 2,397,036 30,600,000
Weighted Avg Shares Basic 2,334,136 30,600,000
Net Share Count Change (Normalized) Insufficient evidence Insufficient evidence
Ownership Claim Change (Normalized) Insufficient evidence Insufficient evidence
Quarterly Financials

Latest quarterly periods, newest first. Periods are shown only when Data Vault has them.

Only 3 quarterly periods available from Data Vault for this company.

Metric
2024-12-31
6-K
USD
2024-06-30
6-K
USD
2023-12-31
6-K
USD
Revenue 23,954,998 1,185,130 23,503,910
Operating Income -127,351 1,717,248 818,372
Net Income -232,533 531,469 760,198
Cash From Operations -2,250,334 -747,576 301,000
Capex -5,135 -55,367 -16,162
Free Cash Flow -2,255,469 -802,943 284,838
Cash And Equivalents n/a 6,655,734 n/a
Total Current Assets 19,820,350 15,379,830 n/a
Total Liabilities 3,324,049 4,234,618 n/a
Shares Outstanding n/a n/a n/a
Shares Outstanding Diluted n/a n/a n/a
Weighted Avg Shares Diluted 1,814,800 30,600,000 1,179,200
Weighted Avg Shares Basic 1,814,800 30,600,000 1,179,200
Net Share Count Change (Normalized) Insufficient evidence Insufficient evidence Insufficient evidence
Ownership Claim Change (Normalized) Insufficient evidence Insufficient evidence Insufficient evidence
Audit Trail

NCAV Audit

Official-source inputs remain linked to filing provenance. Derived values are labeled as such.

Input Value Source concept Filing period Confidence Provenance
Current Assets 19,820,350USD us-gaap:AssetsCurrent 2024-12-31 1.00 Data Vault | sec/companyfacts/cik=0001954594/companyfacts.json
Data Vault | sec/companyfacts/cik=0001954594/companyfacts.json
Total Liabilities 3,324,049USD us-gaap:Liabilities 2024-12-31 1.00 Data Vault | sec/companyfacts/cik=0001954594/companyfacts.json
Data Vault | sec/companyfacts/cik=0001954594/companyfacts.json
Cash n/a derived 2024-12-31 n/a n/a
Shares Outstanding 1,814,800 us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding 2024-12-31 1.00 Data Vault | sec/companyfacts/cik=0001954594/companyfacts.json
Data Vault | sec/companyfacts/cik=0001954594/companyfacts.json
NCAV 16,496,301USD derived 2024-12-31 n/a company-evidence-v1 | total_current_assets - total_liabilities
NCAV per share 9.09USD derived 2024-12-31 n/a company-evidence-v1 | NCAV / shares_outstanding
Internal NCAV Discount 94.4% derived 2024-12-31 n/a gnni_publication_pack | internal_discount

NCAV = total_current_assets - total_liabilities | NCAV per share = NCAV / weighted_avg_shares_diluted

Source Provenance

Data Source
Data Vault
Data Vault Root
n/a
CIK
0001954594
Company ID
n/a
Selected Annual Source
n/a
Selected Quarterly Source
n/a
Statement Extractor
companyfacts-screener-v1
View Extractor
companyfacts-screener-v1
Source Accession Count
3
Imported At
2026-08-15T12:52:08+00:00
Rendered At
2026-08-16T03:29:38+00:00

Run Audit

Mary Run
7597e71d9e0c42a48d3fa1ce89682485
Mary As Of
2026-07-11
Accession
0001213900-25-100369
CIK
0001954594
Mary Filing Date
2025-10-20
Filing Currency
USD
Internal Discount
94.4%
Source State
Stale Filing
Market Context
Not Displayed
Market Policy
internal_only_not_redistributed
Share Trend
Not Evaluated
Dilution
Needs Review

mary_run=7597e71d9e0c42a48d3fa1ce89682485; mary_as_of=2026-07-11; mary_filing_date=2025-10-20; mary_accession=0001213900-25-100369; mary_cik=0001954594; gnni_supporting_filing_date=2025-10-20; internal_discount=0.944069; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot.; source requires review

Back to Register Report a correction Archive